Church F C, Lundblad R L, Noyes C M
J Biol Chem. 1985 Apr 25;260(8):4936-40.
Diethyl pyrocarbonate (ethoxyformic anhydride) was used to modify histidyl residues in prothrombin. Diethyl pyrocarbonate inactivated the potential fibrinogen-clotting activity of prothrombin with a second-order rate constant of 70 M-1 min-1 at pH 6.0 and 25 degrees C. The difference spectrum of the modified protein had a maximum absorption at 240 nm which is characteristic of N-carbethoxyhistidine. The pH dependence for inactivation suggested the participation of a residue with a pKa of 6.2. Addition of hydroxylamine to ethoxyformylated prothrombin reversed the loss of fibrinogen-clotting activity. No structural differences were detected between the native and modified proteins using fluorescence emission and high-performance size-exclusion chromatography. The tyrosine and tryptophan content was not altered, but approximately 1-2 amino groups were modified. Statistical analysis of residual enzyme activity and extent of modification indicates that among 7 histidyl residues modified per molecule, there is 1 essential histidine (not in the active site) involved in the potential fibrinogen-clotting activity of prothrombin. To further examine its properties, the modified prothrombin was activated to thrombin using Echis carinatus venom protease. There was no difference in the catalytic activity of thrombin obtained from either native or ethoxyformylated prothrombin, as measured by H-D-Phe-pipecolyl-Arg-p-nitroanilide (D-Phe-Pip-Arg-NA) hydrolysis. However, thrombin produced from the modified protein showed a loss of fibrinogen-clotting activity but had a comparable apparent Ki value (about 20 microM) to thrombin from native prothrombin when fibrinogen was used as a competitive inhibitor during D-Phe-Pip-Arg-NA hydrolysis. The similarity in Ki values indicated that thrombin derived from diethyl pyrocarbonate-modified prothrombin does not have an altered fibrinogen-binding site. Although the histidyl residue involved during inactivation has not been identified, the results suggest that a histidyl residue in the thrombin portion of prothrombin is essential for interaction with fibrinogen.
焦碳酸二乙酯(乙氧基甲酸酐)被用于修饰凝血酶原中的组氨酸残基。在pH 6.0和25℃条件下,焦碳酸二乙酯使凝血酶原潜在的纤维蛋白原凝血活性失活,二级反应速率常数为70 M-1 min-1。修饰后蛋白质的差示光谱在240 nm处有最大吸收峰,这是N-乙氧羰基组氨酸的特征。失活的pH依赖性表明有一个pKa为6.2的残基参与其中。向乙氧基甲酰化的凝血酶原中加入羟胺可逆转纤维蛋白原凝血活性的丧失。使用荧光发射和高效尺寸排阻色谱法未检测到天然蛋白质和修饰后蛋白质之间的结构差异。酪氨酸和色氨酸含量未改变,但约有1 - 2个氨基被修饰。对残留酶活性和修饰程度的统计分析表明,在每分子修饰的7个组氨酸残基中,有1个必需组氨酸(不在活性位点)参与凝血酶原潜在的纤维蛋白原凝血活性。为进一步研究其性质,使用锯鳞蝰蛇毒蛋白酶将修饰后的凝血酶原激活为凝血酶。通过H-D-苯丙氨酸-哌啶基-精氨酸-对硝基苯胺(D-苯丙氨酸-哌啶-精氨酸-NA)水解测定,从天然或乙氧基甲酰化凝血酶原获得的凝血酶的催化活性没有差异。然而,由修饰后蛋白质产生的凝血酶显示纤维蛋白原凝血活性丧失,但在D-苯丙氨酸-哌啶-精氨酸-NA水解过程中,当纤维蛋白原用作竞争性抑制剂时,其表观Ki值(约20 microM)与天然凝血酶原产生的凝血酶相当。Ki值的相似性表明,源自焦碳酸二乙酯修饰凝血酶原的凝血酶的纤维蛋白原结合位点没有改变。尽管失活过程中涉及的组氨酸残基尚未确定,但结果表明凝血酶原中凝血酶部分的一个组氨酸残基对于与纤维蛋白原的相互作用至关重要。